checkAd

    Median Technologies  105  0 Kommentare Disclosure of total number of voting rights and number of shares in the capital as of May 31st, 2024

    Regulatory News:

    Median Technologies (Paris:ALMDT):

    Total number of shares

    18,418,233

    Number of real voting rights* (excluding treasury shares**)

    18,373,987

    Theoretical number of voting rights* (including treasury shares**)

    18,352,941

    (*) Class E preference shares are non-voting
    (**) pursuant to article 223-11 of the AMF’s General Regulations

    About Median Technologies: Pioneering in innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to elevate the accuracy of early cancer diagnoses and cancer treatments. Median's offerings, including iCRO for medical image analysis and management in oncology trials and eyonis, AI/ML tech-based suite of software as medical devices (SaMD), empower biopharmaceutical entities and clinicians to advance patient care and expedite novel therapies. The French-based company, with a presence in the U.S. and China, is listed on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME). For more information: www.mediantechnologies.com


    The Median Technologies Stock at the time of publication of the news with a raise of +0,72 % to 3,14EUR on Lang & Schwarz stock exchange (07. Juni 2024, 17:43 Uhr).


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Median Technologies Disclosure of total number of voting rights and number of shares in the capital as of May 31st, 2024 Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares 18,418,233 Number of real voting rights* (excluding treasury shares**) 18,373,987 Theoretical number of voting rights* (including treasury shares**) 18,352,941 (*) Class E …

    Schreibe Deinen Kommentar

    Disclaimer